AI assistant
Sending…
PRECIGEN, INC. — Director's Dealing 2015
Dec 7, 2015
32044_dirs_2015-12-07_d0f7cf1d-436a-48c2-88cc-1c67b98145ef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2015-12-03
Reporting Person: Reed Thomas D. (Chief Science Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-03 | Common Stock | A | 64117 | $1.29 | Acquired | 64117 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-03 | Option to Purchase Common Stock (Right to Buy) | $1.29 | D | 64117 | Disposed | 2016-02-07 | Common Stock (64117) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2440 | Indirect |
| Common Stock | 79340 | Indirect |
| Common Stock | 253005 | Indirect |
Footnotes
F1: Held by Jacquelyn Ann Reed, spouse.
F2: Held by Thomas David Reed, Trustee of the Thomas David Reed Living Trust dated February 4, 2011.
F3: Held by Jacquelyn Ann Reed, Trustee of the Jacquelyn Ann Reed Living Trust dated Febrary 4, 2011.
F4: These options were immediately exercisable.
More from PRECIGEN, INC.
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Jan 23
Director's Dealing
2025
Dec 23